VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 129 filers reported holding VENTYX BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,821,536 | -33.4% | 340,384 | -37.1% | 0.25% | -22.0% |
| Q2 2023 | $17,744,275 | -9.5% | 540,984 | -7.5% | 0.32% | -16.4% |
| Q1 2023 | $19,597,500 | -35.4% | 585,000 | -36.8% | 0.38% | -33.6% |
| Q4 2022 | $30,330,750 | +286.1% | 925,000 | +311.1% | 0.58% | +297.3% |
| Q3 2022 | $7,855,000 | -50.2% | 225,000 | -82.5% | 0.15% | -49.0% |
| Q2 2022 | $15,768,000 | -9.9% | 1,289,280 | 0.0% | 0.29% | +0.7% |
| Q1 2022 | $17,496,000 | -31.7% | 1,289,280 | 0.0% | 0.28% | -13.7% |
| Q4 2021 | $25,605,000 | – | 1,289,280 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 3,461,536 | $113,503,765 | 35.19% |
| Qiming U.S. Ventures Management, LLC | 746,370 | $24,473,472 | 32.37% |
| Vivo Capital, LLC | 1,303,294 | $42,735 | 4.92% |
| ACUTA CAPITAL PARTNERS, LLC | 290,500 | $7,558,095 | 4.65% |
| TCG Crossover Management, LLC | 787,231 | $25,813,304 | 4.56% |
| Affinity Asset Advisors, LLC | 240,623 | $7,890,028 | 3.09% |
| GREAT POINT PARTNERS LLC | 400,695 | $13,138,789 | 2.58% |
| Logos Global Management LP | 657,016 | $21,543,555 | 2.52% |
| Cormorant Asset Management, LP | 1,080,643 | $35,434 | 2.37% |
| Boxer Capital, LLC | 850,000 | $27,871,500 | 1.47% |